Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Eton Pharmaceuticals (ETON)

Eton Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ETON
DateTimeSourceHeadlineSymbolCompany
09/05/202421:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ETONEton Pharmaceuticals Inc
09/05/202421:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
09/05/202421:01GlobeNewswire Inc.Eton Pharmaceuticals Reports First Quarter 2024 Financial ResultsNASDAQ:ETONEton Pharmaceuticals Inc
01/05/202421:05GlobeNewswire Inc.Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences ConferenceNASDAQ:ETONEton Pharmaceuticals Inc
30/04/202412:00GlobeNewswire Inc.Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)NASDAQ:ETONEton Pharmaceuticals Inc
29/04/202421:30GlobeNewswire Inc.Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024NASDAQ:ETONEton Pharmaceuticals Inc
22/03/202406:00GlobeNewswire Inc.Eton Pharmaceuticals Announces Acquisition of PKU GOLIKEĀ® for PhenylketonuriaNASDAQ:ETONEton Pharmaceuticals Inc
14/03/202420:01GlobeNewswire Inc.Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:ETONEton Pharmaceuticals Inc
29/02/202421:01GlobeNewswire Inc.Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024NASDAQ:ETONEton Pharmaceuticals Inc
21/02/202411:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
21/02/202411:50GlobeNewswire Inc.Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid FormulationNASDAQ:ETONEton Pharmaceuticals Inc
15/02/202421:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETONEton Pharmaceuticals Inc
15/02/202421:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETONEton Pharmaceuticals Inc
15/02/202421:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETONEton Pharmaceuticals Inc
02/02/202411:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
02/02/202411:50GlobeNewswire Inc.Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone CapsulesNASDAQ:ETONEton Pharmaceuticals Inc
09/11/202321:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ETONEton Pharmaceuticals Inc
09/11/202321:01GlobeNewswire Inc.Eton Pharmaceuticals Reports Third Quarter 2023 Financial ResultsNASDAQ:ETONEton Pharmaceuticals Inc
30/10/202310:50GlobeNewswire Inc.Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023NASDAQ:ETONEton Pharmaceuticals Inc
18/10/202313:00PR Newswire (US)SWK Holdings Highlights Recent Achievements and Provides Portfolio UpdateNASDAQ:ETONEton Pharmaceuticals Inc
04/10/202311:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
04/10/202311:50GlobeNewswire Inc.Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product NitisinoneNASDAQ:ETONEton Pharmaceuticals Inc
23/08/202311:50GlobeNewswire Inc.Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:ETONEton Pharmaceuticals Inc
10/08/202321:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ETONEton Pharmaceuticals Inc
10/08/202321:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETONEton Pharmaceuticals Inc
10/08/202321:01GlobeNewswire Inc.Eton Pharmaceuticals Reports Second Quarter 2023 Financial ResultsNASDAQ:ETONEton Pharmaceuticals Inc
01/08/202321:05GlobeNewswire Inc.Eton Pharmaceuticals to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023NASDAQ:ETONEton Pharmaceuticals Inc
17/07/202321:05PR Newswire (US)SWK Holdings Highlights Recent Achievements and Provides Portfolio UpdateNASDAQ:ETONEton Pharmaceuticals Inc
28/06/202312:42Dow Jones NewsEton Pharma Gets FDA Complete Response Letter for Dehydrated Alcohol InjectionNASDAQ:ETONEton Pharmaceuticals Inc
28/06/202311:56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETONEton Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ETON